Navigation Links
Aging Population, Heightened Consumer Awareness Propel U.S. Bone and Joint Health Ingredients, Says Frost & Sullivan
Date:9/3/2009

MOUNTAIN VIEW, Calif., Sept. 3 /PRNewswire/ -- An expanding aging population and increased consumer awareness boosts growth for the U.S. bone and joint health ingredients market. Consumers increasingly seek supplements and functional foods that enhance their wellness quotient and have strong scientific backup. The rise in the incidence of osteoporosis and osteoarthritis reinforces the need for well-researched ingredients that deliver tangible advantages.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

Osteoporosis and osteoarthritis spread at an alarming rate in the U.S., affecting nearly 44 million and 34 million people, respectively. The estimated cost of osteoporosis-related fractures was estimated at $19 billion in 2005, and it is projected to reach $25.3 billion in 2025.

New analysis from Frost & Sullivan (http://www.food.frost.com), U.S. Bone and Joint Health Ingredients Market, finds the market earned revenues of over $178.4 million in 2008 and estimates to reach $246.4 million in 2015. The study offers individual market forecasts for calcium, prebiotics, soy isoflavones, glucosamine, and chondroitin sulfate. In addition, it provides qualitative analysis of ingredients such as vitamin D, methyl sulfonyl methane (MSM), hyaluronic acid, collagen, and other botanicals positioned for bone and joint health benefits.

If you are interested in a virtual brochure, which provides a brief synopsis of the research and a table of contents, then send an e-mail to Johanna Haynes, Corporate Communications, at johanna.haynes@frost.com, with your full name, company name, title, telephone number, company e-mail address, company website, city, state and country. Upon receipt of the above information, a brochure will be sent to you by e-mail.

"Traditionally, bone health supplements were predominantly targeted to women and individuals above 60 years of age," says Frost & Sullivan Research Analyst Arthi.V. "However, this target group is widening, with an increasing number of men and younger adults being diagnosed with osteoporosis or at high risk due to low bone mass."

The National Institute on Aging reported that in the U.S. more than two million men have osteoporosis, with over three million at high risk of contracting this disease.

The prominent competitive factors in the U.S. bone and joint health ingredients market include price, quality, distribution efficiency, ability to provide a point of differentiation through novel ingredient combinations, and value-added services that include assistance in product formulation and regulatory support.

The ongoing economic slowdown is a key factor affecting the food and beverage industry. While the average share of consumers' food budget relative to their total income increases, there is a shift from lavish spending to a more conservative purchase pattern. Consumers move away from specialty products and opt for value alternatives.

Tight financial resources, however, reduce manufacturer spending on product innovation at the ingredient and end-product level. Furthermore, the U.S. bone and joint health ingredients market faces stiff competition from Asian manufacturers in certain market segments such as glucosamine, chondroitin sulfate, hyaluronic acid, and isoflavones. These low-cost alternatives have narrowed the margins for local manufacturers. The U.S. market is already highly price sensitive, and competition from Asian manufacturers amplifies this price sensitivity.

In addition, there is a growing threat from alternative ingredients, particularly in the joint care segment. Glucosamine and chondroitin sulfate are established in this sector, but newer ingredients are positioned for joint health benefits. The market is also confronted with issues concerning ingredient purity.

"Maintaining high quality standards will enable manufacturers to gain consumer confidence and loyalty," states the analyst. "This will also guarantee the steady demand for existing ingredients despite the widening array of alternatives in the market."

U.S. Bone and Joint Health Ingredients Market is part of the Food and Beverage Ingredients Growth Partnership Services program, which also includes research in the following markets: The European Bone & Joint Health Ingredients Markets, U.S. Prebiotics Market, and European Prebiotics Market. All research services included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 35 offices on six continents. To join our Growth Partnership, please visit http://www.frost.com.

U.S. Bone and Joint Health Ingredients Market

N58B

    Contact:

    Johanna Haynes
    Corporate Communications - North America
    P: 210.247.3870
    F: 210.348.1003
    E: johanna.haynes@frost.com

http://www.frost.com


'/>"/>
SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Stanford researchers find culprit in aging muscles that heal poorly
2. Brain imaging reveals breakdown of normal emotional processing
3. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
4. Oncologists are critical in managing psychiatric disorders in patients with advanced cancer
5. Fry Construction Selected for High-Profile Medical Imaging Project
6. September is Healthy Aging Month
7. The era of global aging: GSAs annual meeting to present new research on hot topics in aging
8. Elbit Medical Imaging Ltd. Announces Publication of a Prospectus in Israel
9. U.S. Health Initiative Targets Aging Hispanics
10. Ultrasonix Adds Global Medical Imaging Into Its North American Sales Force
11. Imaging Software Helps Track, Treat Injured Brains
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2017)... ... 2017 , ... The Pennsylvania Athletic Trainers’ Society’s (PATS) Annual ... Convention Center on June 8-10. The weekend consisted of many educational presentations, ... scholarship presentations, and professional networking. , On Friday June 9th, PATS hosted ...
(Date:6/24/2017)... ... June 24, 2017 , ... The weather is heating up and ... and business owners should be aware that the summer months provide more than warmer ... locks and keys can be negatively affected from direct exposure to the sun. When ...
(Date:6/23/2017)... ... June 23, 2017 , ... The Rhode Island Quality Institute ... Alerts and Dashboards, an innovative new service enabling healthcare providers to proactively coordinate ... Alerts and Dashboards provide near real-time data about patients admitted to and/or discharged ...
(Date:6/23/2017)... ... , ... By scoring 100% for fiscal management and accountability, the Arthritis National ... evaluator, Charity Navigator, validating ANRF's work as a top charity in America. , This ... and earns ANRF a spot on their “ 10 Charities Worth Watching ” list ...
(Date:6/23/2017)... ... June 24, 2017 , ... Studies show evidence that carotenoids and ... of visual loss in these patients. , But how often do ophthalmologists and optometrists ... to patients at risk of or with early symptoms of AMD? A study ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... 2017  Less than a month ago, amateur hackers ... companies, including hospital networks, in over 150 countries. ... the largest online extortion attempts ever recorded. With the ... is imperative that providers understand where the risks lie, ... — and many other very real cyber threats.  ...
(Date:6/7/2017)... -- Novavax, Inc., (Nasdaq: NVAX ) today announced that ... its RSV F protein recombinant nanoparticle vaccine candidate (RSV F ... in the journal Vaccine (the data ... conferences). The Company previously announced top line results ... RSV F Vaccine with the goal of protecting infants from ...
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
Breaking Medicine Technology: